Research-Grade Finasteride Overview
Finasteride IP 1 mg is a 5α-reductase inhibitor manufactured by HAB Pharmaceuticals for laboratory research applications. This pharmaceutical compound selectively inhibits the Type II 5α-reductase enzyme, which catalyses the conversion of testosterone to dihydrotestosterone (DHT) in preclinical models. Finasteride demonstrates high specificity for the 5α-reductase pathway and has been extensively studied in androgenic research protocols. Researchers at Stroid UK Shop investigate this compound for its molecular mechanisms in hormonal pathway modulation.
Laboratory Research Applications
Research scientists utilise finasteride to examine DHT-mediated pathways in cellular and tissue models. Studies have focused on investigating the compound’s effects on androgen receptor signalling cascades and hormonal feedback mechanisms. The pharmaceutical-grade formulation ensures consistent results in experimental protocols examining 5α-reductase inhibition. Researchers working with aromatase inhibitors and finasteride compounds analyse the biochemical pathways involved in steroidogenesis. Laboratory applications include investigating hormonal modulation effects in controlled research environments, examining enzyme kinetics, and studying androgenic pathway interactions. Scientists also research the compound’s pharmacological properties alongside other research chemicals available from SARMs collections and peptide research compounds for comprehensive hormonal studies.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Finasteride |
| Concentration | 1 mg per tablet |
| Manufacturer | HAB Pharmaceuticals |
| CAS Number | 98319-26-7 |
| Molecular Formula | C₂₃H₃₆N₂O₂ |
| Molecular Weight | 372.55 g/mol |
| Storage | Room temperature, dry environment |
| Purity | Pharmaceutical grade |
Research Compliance Statement
This finasteride product is manufactured strictly for in-vitro laboratory research applications only. HAB Pharmaceuticals finasteride IP 1 mg tablets are intended solely for qualified researchers conducting studies on 5α-reductase inhibition and androgenic pathways. This compound is not intended for human consumption, therapeutic use, or any application outside controlled laboratory research environments. Researchers must comply with institutional guidelines and applicable regulations when handling pharmaceutical research compounds.
